Table I. Demographics of subjects
At-Risk Subjects
Groupn (Male Sex)Median Age (Range, y) at First CollectionMedian No. of Positive AutoantibodiesMedian Interval Followed (Range, d)
Progressors9 (3)17.0 (7.6–41.2)3383 (146–672)
Nonprogressors13 (7)15.9 (6.5–39.2)1585 (343–742)
Subjects with Diabetes
GroupnMedian Age (Range, y)Median Disease Duration (Range, y)
Female921.1 (13.7–46)5.92 (2.67–38)
Male1419.5 (13.4–34)10.1 (3.6–27)